SPYRE THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $434.90M.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $9.75M.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2019-03-31 was $64.50M.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2018-06-30 was $37.66M.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $197.36M.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $54.05M, a 374.94% increase from fiscal 2017.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2017 was $11.38M, a 75.92% decline from fiscal 2016.
- SPYRE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2016 was $47.27M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $434.90M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $9.75M 10-Q · filed 2026-08-04 | |
| 2023-12-31 | $197.36M 10-K/A · filed 2024-11-18 | |
| 2019-03-31 | $64.50M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $54.05M 10-K · filed 2021-03-18 | |
| 2018-06-30 | $37.66M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $11.38M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $47.27M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |